S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
CELZ$0.6375+2.25%
Creative Medical Technology Holdings, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$4.84M
Float & O/S:
Inst Own:
DilutionScan read 28 of CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s SEC filings and found 20 warrant series, 4 shelf registrations, 2 S-1 registrations and 3 completed offerings on file for CELZ. The latest dilution event on file is an offering on Sep 24, 2026. Analysis updated Oct 12, 2026.
Signal8 Summary
CELZ
Tight cash runway and heavy dilution
Snapshot
This is a pre-revenue biotechnology company burning cash rapidly. With only $6K in revenue for FY 2025 against a $6M net loss, the business relies entirely on external capital. The company holds $7.2M in cash but burns roughly $5.9M annually, leaving a tight cash runway of about 7.4 months.
What's Happening Right Now
- : The company received a Notice of Allowance for a new U.S. patent covering exosome-based immunotherapy for Type 1 Diabetes.
- : A proxy statement seeks approval to increase authorized shares four-fold and exercise warrants that would dilute existing shareholders by over 100%.
- : The company entered agreements for the immediate exercise of warrants expected to generate $4.5 million in gross proceeds.
- : The FDA cleared an expansion of the ADAPT trial evaluating CELZ-201 for chronic lower back pain.
Raise routes on file: effective shelf + pending S-1 + effective S-1 · latest dilution event 40 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 24, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
June 2026 Inducement Warrants
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
October 2025 Inducement Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
March 2025 Inducement Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
March 2025 Inducement Warrants — October 2025 exercise
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your CELZ trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
